CABA Stock Analysis: Buy, Sell, or Hold?
CABA - Cabaletta Bio, Inc. Common Stock
$2.83
0.15 (5.41%)
▲
5d:
+0.18%
30d:
-17.64%
90d:
+29.0%
BUY
HIGH Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 21, 2026
Smart Money Accumulation
CABA is down 8.8% this week, but smart money is accumulating calls. Top strike: $2.5 2026-05-15 with 15,057 OI. Call ratio: 100% View Scanner →
Strength: 9.4/10
Get Alerted When CABA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: CABA shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: CABA shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: CABA is currently trading at $2.83, which is considered slightly low relative to its 30-day fair value range of $2.78 to $3.33.
Technical Outlook: Technically, CABA is in a downtrend. Immediate support is located at $2.45, while resistance sits at $3.25. The stock is showing strong short-term momentum, up 5.4% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $13.12 (+389.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CABA is in a downtrend. Immediate support is located at $2.45, while resistance sits at $3.25. The stock is showing strong short-term momentum, up 5.4% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $13.12 (+389.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$2.78 -
$3.33
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.4%)
- BULLISH: Trading 389.7% below Wall St target ($13.12)
Fair Price Analysis
30-Day Fair Range
$2.78 -
$3.33
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$2.45
Resistance Level
$3.25
Current Trend
Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.72
Wall Street Target
$13.13
(+389.7%)
Share & Embed Analysis
Last updated: April 02, 2026 12:45 PM ET
Data refreshes hourly during market hours. Next update: 1:45 PM
Data refreshes hourly during market hours. Next update: 1:45 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CABA showing a specific setup today?
Insider Activity (6 Months)
7
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
David J Chang
BUY
8800 shares
2026-01-21
Gwendolyn Binder
BUY
11312 shares
2026-01-21
Mark Simon
BUY
11061 shares
2026-01-21
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$54 | 63 BUY |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$92 | 63 BUY |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$108 | 66 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 57 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 45 HOLD |
